These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 12472675)
41. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis. Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436 [TBL] [Abstract][Full Text] [Related]
42. Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis? Comay D; Cauch-Dudek K; Hemphill D; Diamandis E; Wanless I; Heathcote EJ Dig Dis Sci; 2000 Oct; 45(10):2018-21. PubMed ID: 11117577 [TBL] [Abstract][Full Text] [Related]
43. Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay. Villalta D; Sorrentino MC; Girolami E; Tampoia M; Alessio MG; Brusca I; Daves M; Porcelli B; Barberio G; Bizzaro N; Clin Chim Acta; 2015 Jan; 438():135-8. PubMed ID: 25172039 [TBL] [Abstract][Full Text] [Related]
44. Autoantigens in primary biliary cirrhosis. Jones DE J Clin Pathol; 2000 Nov; 53(11):813-21. PubMed ID: 11127262 [TBL] [Abstract][Full Text] [Related]
45. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Tsuneyama K; Van De Water J; Van Thiel D; Coppel R; Ruebner B; Nakanuma Y; Dickson ER; Gershwin ME Hepatology; 1995 Nov; 22(5):1440-6. PubMed ID: 7590661 [TBL] [Abstract][Full Text] [Related]
47. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646 [TBL] [Abstract][Full Text] [Related]
48. Prevalence and impact of Sjögren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis. Deng X; Li J; Hou S; Ci B; Liu B; Xu K Ann Hepatol; 2022; 27(6):100746. PubMed ID: 35970319 [TBL] [Abstract][Full Text] [Related]
49. [Western blot analysis of anti-M2 antibodies in anti-mitochondrial antibody-negative primary biliary cirrhosis]. Kawaguchi N; Miyakawa H; Abe K; Kitazawa E; Fujikawa H; Kikuchi K; Kako M; Shibata M; Shibuya A; Onozuka Y; Yoshida N; Ueno Y Rinsho Byori; 1997 Nov; 45(11):1079-84. PubMed ID: 9396349 [TBL] [Abstract][Full Text] [Related]
50. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations]. Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329 [TBL] [Abstract][Full Text] [Related]
51. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis. Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809 [TBL] [Abstract][Full Text] [Related]
52. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Terjung B; Spengler U Clin Rev Allergy Immunol; 2005 Apr; 28(2):115-33. PubMed ID: 15879618 [TBL] [Abstract][Full Text] [Related]
53. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis. Hu C; Deng C; Song G; Zhang W; Zhang S; Li X; Li P; Zhang F; Li Y Dig Dis Sci; 2011 Nov; 56(11):3357-63. PubMed ID: 21660486 [TBL] [Abstract][Full Text] [Related]
54. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656 [TBL] [Abstract][Full Text] [Related]
55. Diagnostic Dilemma in the Detection of Antibodies to Filamentous Actin. Himoto T; Fujita K; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Haba R; Masaki T Clin Lab; 2016; 62(5):839-47. PubMed ID: 27349009 [TBL] [Abstract][Full Text] [Related]
57. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases. Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714 [TBL] [Abstract][Full Text] [Related]